ScreenerHero

IQV IQVIA Holdings Inc.

NYSE · US · Healthcare · Diagnostics & Research · iqvia.com
266.09USD+3.05%Mkt Cap: 43.80B $P/E: 33.05

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates …

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2
GRAL
GRAIL, Inc.
$6.88BUSD

Key Statistics

Company
Market Cap43.80B USD
Enterprise Value56.81B USD
Revenue (TTM)16.98B USD
Gross Profit5.43B USD
Net Income (TTM)1.36B USD
Revenue/Share100.70 USD
Last Price266.09 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees94.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)33.05
P/E (Forward)17.84
PEG0.94
EV/EBITDA18.64
EV/Revenue3.34
P/S2.50
P/B6.89
EPS (TTM)8.05
EPS (Forward)14.47
52W Range
154.5091% of range277.40
52W High277.40 USD
52W Low154.50 USD
Profitability
Gross Margin33.29%
Oper. Margin13.03%
EBITDA Margin17.95%
Profit Margin8.34%
ROE20.91%
ROA4.54%
Growth
Revenue Growth8.70%
Earnings Growth-0.60%
Cash Flow & Leverage
Operating CF2.65B USD
CapEx (TTM)603.00M USD
FCF Margin12.66%
FCF Yield4.91%
Net Debt14.17B USD
Net Debt/EBITDA4.65
Balance Sheet
Debt/Equity2.14
Current Ratio0.71
Quick Ratio0.62
Book Value/Sh37.49 USD
Cash/Share12.64 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)288.74 USD
Upside (mean)+8.5%
Target Range250.00 USD – 345.00 USD
250.00+8.5% to mean345.00
# Analysts19
Ownership
Shares Out.164.60M
Float156.25M
Insiders1.09%
Institutions103.48%
Short Interest
Short Ratio3.1d
Short % Float2.90%
Short % Out.2.50%
Shares Short4.12M
Short (prev mo.)4.25M
Technical
SMA 50253.80 (+4.8%)
SMA 200205.83 (+29.3%)
Beta1.19
S&P 52W Chg14.58%
Avg Vol (30d)1.51M
Avg Vol (10d)1.42M
Technical Indicators
RSI (14)54.1
MACD3.4067
MACD Signal5.4624
MACD Hist.-2.0557
BB Upper276.58 USD
BB Middle266.12 USD
BB Lower255.66 USD
BB Width7.86%
ATR (14)7.105 USD
Vol Ratio (20d)1.02x